CENTRACAN INC
RW, 2000-10-02
MEDICAL LABORATORIES
Previous: WADDELL & REED ADVISORS SMALL CAP FUND INC, 497, 2000-10-02
Next: RELIANT INTERACTIVE MEDIA CORP, DEF 14C, 2000-10-02



                           CENTRICAN SUPPLEMENTS CORP.
                              4255 Route 9, Suite D
                           Freehold, New Jersey 07728


September 28, 2000

VIA FEDERAL EXPRESS

Securities and Exchange Commission
Judiciary Plaza
450 Fifth Street, N.W.
Washington DC 20549

            Re:         CentraCan Supplements Corp.
                        Registration Statement on Form S-4
                        File No. 333-71935
                        ----------------------------------

Gentlemen:

            Pursuant  to Rule 477 under the  Securities  Act of 1933,  CentraCan
Supplements Corp.  ("CentraCan") hereby respectfully  requests the withdrawal of
its Registration  Statement on Form S-4, File No. 333-71935.  No securities have
been or will be issued, exchanged or sold under the Registration Statement.

            CentraCan is requesting withdrawal of the Registration Statement due
to the termination of the Asset Purchase Agreement,  as amended, dated as of May
20, 2000,  between  CentraCan,  HMC Acquisition Corp. and Healthcare  Management
Merger  Company,  Inc.  The  termination  of the Asset  Purchase  Agreement  was
effective as of September  28, 2000,  the date  CentraCan  signed a  termination
agreement with HMC Acquisition  Corp. and Healthcare  Management Merger Company,
Inc.

            Accordingly,  we request an order  granting  the  withdrawal  of the
Registration  Statement be issued by the Securities  and Exchange  Commission as
soon as possible.

            If you have any  questions  regarding  this matter,  please  contact
CentraCan at (732) 409-1212,  or Kenneth A. Schlesinger of Olshan Grundman Frome
Rosenzweig & Wolosky LLP at (212) 451-2252.


                                        Very truly yours,

                                        /s/ Richard Talley
                                        Richard Talley
                                        Chairman of the Board


cc:  Kenneth A. Schlesinger, Esq.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission